Yasmin Clarke

Experts / Yasmin Clarke

Data analyst; Journalist

Yasmin Clarke is a data analyst & visualisation expert who has provided insights for the NSW Department of Education; the Independent Hospital Pricing Authority; LG Professionals Australia; Roads and Maritime Service (RMS); Transurban; IBM among others. She has a background in science, accounting, and business strategy.

Exclusive: Only 25% of GPs see value in RACGP membership

Exclusive data from Healthed’s latest survey reveals that few GPs see RACGP membership as providing value for money, even though GPs are much more likely to recommend the college to their peers than any time in the last four years.

Infectious diseases, Public health

Clinical Articles

Almost 90% of GPs want mask mandates

The majority of the 477 GPs surveyed this month by Healthed say Australia should reintroduce mask mandates for crowded, indoor settings

Lagevrio recommended surprisingly often, given recommendations against routine-use

Guidelines say Paxlovid more effective than Lagevrio - yet prescribing rates appear to be similar

By Yasmin Clarke, Lynnette Hoffman

Clinical Articles

Drugs and devices

Why aren’t more patients receiving IV iron?

43% of GPs had at least one patient in the last month who wasn’t able to access IV iron they needed

By Lynnette Hoffman, Yasmin Clarke

Clinical Articles

Haematology

Yasmin Clarke

Data analyst; Journalist

More from this expert

Exclusive: Only 25% of GPs see value in RACGP membership

Exclusive data from Healthed’s latest survey reveals that few GPs see RACGP membership as providing value for money, even though GPs are much more likely to recommend the college to their peers than any time in the last four years.

Almost 90% of GPs want mask mandates

The majority of the 477 GPs surveyed this month by Healthed say Australia should reintroduce mask mandates for crowded, indoor settings

Lagevrio recommended surprisingly often, given recommendations against routine-use

Guidelines say Paxlovid more effective than Lagevrio - yet prescribing rates appear to be similar

Why aren’t more patients receiving IV iron?

43% of GPs had at least one patient in the last month who wasn’t able to access IV iron they needed

Get the app

Site

Company

Connect

Legal

Discover

Healthed

"Familial Colorectal Cancer" - Upcoming webcast topic

Free lecture from Prof Finlay Macrae AO

We invite you to join the upcoming Healthed webcast where Prof Macrae speak on how GPs can suspect, assess and manage hereditary colorectal cancer risk.

Tuesday 2nd September, 7pm AEST

Yasmin Clarke

Data analyst; Journalist

More from this expert

Exclusive: Only 25% of GPs see value in RACGP membership

Exclusive data from Healthed’s latest survey reveals that few GPs see RACGP membership as providing value for money, even though GPs are much more likely to recommend the college to their peers than any time in the last four years.

Almost 90% of GPs want mask mandates

The majority of the 477 GPs surveyed this month by Healthed say Australia should reintroduce mask mandates for crowded, indoor settings

Lagevrio recommended surprisingly often, given recommendations against routine-use

Guidelines say Paxlovid more effective than Lagevrio - yet prescribing rates appear to be similar

Why aren’t more patients receiving IV iron?

43% of GPs had at least one patient in the last month who wasn’t able to access IV iron they needed

Get the app

Site

Company

Connect

Legal

Save time on registrations, track CPD, listen to full podcasts... sign in to your Healthed account now

Don't have an existing account? Sign up today

Sign up for a free Healthed account

Extra Details

PASSWORD RESET

Discover

Healthed

"Familial Colorectal Cancer" - Upcoming webcast topic

Free lecture from Prof Finlay Macrae AO

We invite you to join the upcoming Healthed webcast where Prof Macrae speak on how GPs can suspect, assess and manage hereditary colorectal cancer risk. Tuesday 2nd September, 7pm AEST

We invite you to join the upcoming Healthed webcast where Prof Macrae speak on how GPs can suspect, assess and manage hereditary colorectal cancer risk.

Tuesday 2nd September, 7pm AEST